Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

NCT: NCT06094608 · RECRUITING

NCT IDNCT06094608
StatusRECRUITING
Start Date2024-02-01
Completion2027-06-30

Brief Summary

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Frequently Asked Questions

What is IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms?

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms is a clinical trial registered under NCT06094608. Current status: RECRUITING.

What is the status of NCT06094608?

The current status of NCT06094608 (IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms) is: RECRUITING.

When did IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms start?

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms started on 2024-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑